European equities traded in the US as American depositary receipts were trending slightly lower late Monday morning, declining 0.16% to 1,278.01 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and semiconductor company Sequans Communications (SQNS), which rose 3.2% and 2.8% respectively. They were followed by medical device maker EDAP TMS (EDAP) and accommodations booking company trivago (TRVG), which were up 2.7% and 1.5% respectively.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ), which fell 2.9%, followed by biotech firm Evaxion Biotech (EVAX) and internet advertising firm Criteo (CRTO), which lost 2.3% each. They were followed by 3D printer company Materialise (MTLS), which was down 2%.
From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma (VRNA) and TC Biopharm (TCBP), which rose 3.7% and 3.1% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which increased 2.1% and 1.8% respectively.
The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biotech firm Autolus Therapeutics (AUTL), which dropped 4.3% and 3.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which lost 3.3% and 3.2% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。